期刊文献+

脑脊液指标对淋巴瘤中枢神经系统浸润的诊断价值 被引量:1

Diagnostic value of cerebrospinal fluid indexes in central nervous system infi ltration of lymphoma
下载PDF
导出
摘要 目的通过分析高危组淋巴瘤患者的脑脊液等临床资料探讨脑脊液指标对于淋巴瘤中枢神经系统(central nervous system,CNS)浸润的诊断价值。方法回顾性分析2015年1月至2021年5月北部战区总医院收治的高危组行腰椎穿刺鞘注的92例淋巴瘤患者的临床资料和脑脊液指标。其中CNS浸润患者(CNS组)16例(17.4%)和非CNS浸润患者(non-CNS组)76例(82.6%)。比较两组患者的临床特征和脑脊液指标(包括颅内压力、蛋白定量、潘氏试验、有核细胞计数和淋巴瘤细胞等)。结果CNS组与non-CNS组患者在初始累及高危部位、头颅影像学结果、美国东部肿瘤协作组(Eastern Cooperative Oncology Group,ECOG)评分和是否进行预防性中枢治疗方面比较,差异均具有统计学意义(均P<0.05),而在性别、年龄、乳酸脱氢酶(lactate dehydrogenase,LDH)水平、β2-微球蛋白(β2-microglobulin,β2-MG)、血清白蛋白(albumin,ALB)、LDH倍数、Lugano分期、CNS-国际预后指数(international prognostic index,IPI)评分、Ki-67指数、淋巴结数量和是否具有大包块方面比较,差异均无统计学意义(均P>0.05)。两组患者在颅内压力、蛋白定量、潘氏试验结果、是否能检测到淋巴瘤细胞和有核细胞计数比较,差异均具有统计学意义(均P<0.05),而在葡萄糖定量方面比较,差异无统计学意义(P>0.05)。分析其中44例弥漫大B细胞淋巴瘤患者显示,CNS组与non-CNS组仅能在有核细胞计数方面比较,差异具有统计学意义(P<0.05),而在颅内压力、蛋白定量、潘氏试验结果、是否能检测到淋巴瘤细胞和葡萄糖定量方面比较,差异均无统计学意义(均P>0.05)。结论脑脊液指标对淋巴瘤CNS浸润诊断有一定的参考意义,但需要更有效的诊断方法。 Objective To evaluate the diagnostic value of cerebrospinal fluid(CSF)indexes in central nervous system(CNS)infiltration of lymphoma by analyzing the clinical data of high-risk lymphoma patients.Methods The clinical data and CSF indexes of 92 patients with lymphoma who were in high risk and underwent lumbar puncture and sheath injection admitted to General Hospital of Northern The-ater Command from January 2015 to May 2021 were retrospectively analyzed.There were 16 patients with CNS infiltration(CNS group)and 76 patients with non-CNS infiltration(non-CNS group).Clinical features and CSF indexes,including intracranial pressure,protein quantification,Pandy's test,nucleated cell count,and lymphoma cells,were compared between the two groups.Results There were sig-nificant differences between the CNS group and non-CNS group in the initial involvement of high-risk sites,skull imaging results,Eastern Cooperative Oncology Group(ECOG)score and whether preventive central treatment was performed(all P<0.05).But the differences in sex,age,lactate dehydrogenase(LDH)level,β2-microglobin(β2-MG),serum albumin(ALB),LDH multiple,Lugano stage,CNS-international prognostic index(IPI)score,Ki-67 index,the number of lymph nodes,and the presence of large lump were not statistically significant(all P>0.05).There were statistically significant differences in intracranial pressure,protein quantification,Pandy's test results,detection of lymphoma cells and nucleated cell count between the two groups(all P<0.05),but there was no significant difference in glucose quantifi-cation(P>0.05).Analysis of 44 patients with diffuse large B cell lymphoma showed that the CNS group and the non-CNS group were only significantly different in nucleated cell count(P<0.05),and there were no significant differences in intracranial pressure,protein quantifi-cation,Pandy's test results,detection of lymphoma cells and glucose quantification(all P>0.05).Conclusions CSF indexes have a certain reference significance in the diagnosis of CNS infiltration of lymphoma,but more effective diagnostic methods are needed.
作者 刘丽欣 刘景华 周凡 王吉刚 刘彦琴 吴泽来 张美玉 Liu Lixin;Liu Jinghua;Zhou Fan;Wang Jigang;Liu Yanqin;Wu Zelai;Zhang Meiyu(Graduate School,Jinzhou Medical University,Jinzhou 121000,China;Department of Hematology,General Hospital of Northern Theater Command,Shenyang 110016,China)
出处 《实用肿瘤杂志》 CAS 2023年第3期265-270,共6页 Journal of Practical Oncology
基金 中国博士后科学基金(2016M593026)。
关键词 淋巴瘤 中枢神经系统浸润 腰椎穿刺 脑脊液 lymphoma central nervous system infiltration lumbar puncture cerebrospinal fluid
  • 相关文献

参考文献11

二级参考文献81

  • 1肖亮生,陈小晶,陈曼娜,邱少雄,许建平.脑膜炎患儿脑脊液中免疫球蛋白及α2-巨球蛋白的检测及临床意义[J].陕西医学杂志,2005,34(1):102-103. 被引量:3
  • 2张福林,汪寅,陈宏,徐启武,陈衔城,周范民,黄峰平,周良辅.5109例中枢神经系统肿瘤WHO新分类统计分析[J].临床与实验病理学杂志,2004,20(6):688-691. 被引量:9
  • 3关鸿志,陈琳,郭玉璞,崔巍,任海涛,赵燕环,高晶,王长华.脑膜淋巴瘤的临床脑脊液细胞学研究[J].中华神经科杂志,2006,39(2):113-117. 被引量:32
  • 4[2]Bollen ELEM, Brouwer RE, Hamers S, et al. Central nervous system relapse in Non - Hodgkin Lymphoma a single - center study of 532 patients. Arch Neurol, 1997,54: 854 ~ 859.
  • 5[3]Hollender A,Kvaloy S,Lote K,et al. Prognostic factors in 140 abult patients with non - Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. Eur J Cancer, 2000, 36: 1762 ~ 1768.
  • 6[4]Gokbuget N, Hoelzer D. Recent approaches in acute lymphoblastic leukemia in adults. Rev Clin Exp Hematol,2002,6:114~141.
  • 7[5]Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol, 2000, 18: 3144 ~ 3150.
  • 8[6]Kantarjian HM,O'Brien S,Smith TL,et al. Results of treatment with hyper - CVAD. a dose - intensive regimen,in adult acute lymphocytic leukemia. J Clin Oncol, 2000,18: 547 ~ 561.
  • 9Hollender A, Kvaloy S, Nome O, et al. Central nervous system involvement following diagnosis of non - Hodgkin' s lymphoma: a risk model. Ann Onco1,2002,13 : 1099 - 1107.
  • 10Bollen EL, Brouwer RE, Hamers S, et al. Central nervous system relapse in non - Hodgkin lymphoma:a single - center study of 532 patients. Arch Neurol, 1997,54 (7) : 854 - 859.

共引文献41

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部